JS BIOMEDICAL LTDActive

Company number 12027360Private limited companyIncorporated 2019

Key figures

£81,560-23.5%
Net assets 2024/25
+29.5%
Average annual growth 2020/21–2024/25
050 k100 k150 k200 k2020/212021/222022/232023/242024/25

Like most small UK companies, JS BIOMEDICAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Turnover——127,440——
Profit for the year——30,811——
Cash at bank and in hand53,04754,40463,45420,2371,721
Total assets57,398221,471143,007107,71027,145
Total liabilities54,92341,4401,8971,2984,862
Net assets / total equity29,043180,031141,144106,60081,560
Average number of employees34444

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: JS BIOMEDICAL LTD

Company

JS BIOMEDICAL LTD is a private limited company registered with Companies House under company number 12027360. It was incorporated on 31 May 2019. Its status is active. The registered office is in Southall (UB1). Its nature of business (SIC 2007) is retail sale via mail order houses or via Internet (47910), other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £81,560, down 23.5% on the previous year. Cash at bank and in hand was £1,721. Total assets were £27,145 and total liabilities £4,862. The company had an average of 4 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 13 Jun 2027.